Back

Oncostatin M reprogrammes cardiac fibroblasts toward an immunoregulatory state

29 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Cardiac repair, regeneration, and cell therapy Fibrosis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ruopu Li

Fuwai Hospital, Beijing (China)

6 More presentations in this session

Presentation thumbnail
Intracoronary administration of GMP-grade MSC-EVs modulates immunity and promotes angiogenesis in a translational porcine MI-reperfusion model
Ms L. Schoch (Badalona, ES)
Abstract Slides Video
Presentation thumbnail
Post-MI bone marrow cell secretome reprograms macrophages to a reparative M2 phenotype, enhancing cardiac repair
Associate Professor M. Giraud (Fribourg, CH)
Abstract Slides Video
Presentation thumbnail
Apoptotic mesenchymal stem cells drive myocardial repair by activating RUNX1-TK1-mediated pyrimidine metabolic reprogramming in macrophages
Miss T. Xiao (CN)
Abstract Slides Video
Presentation thumbnail
ILC2-derived IL-9 activates regulatory T cells to facilitate post-myocardial infarction repair
Doctor Y. Feng (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Exercise training protects against myocardial infarction by regulating B cell infiltration and function
Doctor S. Liu (Shanghai, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac repair, regeneration, and cell therapy

The Event

Event poster

ESC Congress 2026

29 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Cytokines as potential novel therapy targets in inflammatory cardiomyopathy
30 August 2026
thumbnail
Congress Presentation
The transcription factor foxo3 regulates cardiac remodeling after myocardial infarction
1 September 2024
thumbnail
Congress Presentation
IFIT3 defines a novel subset of vascular smooth muscle cells to exacerbate the development of vascular remodeling disease
29 August 2026
thumbnail
Congress Presentation
Preclinical study of FAP-specific CAR-T cells in treating myocardial fibrosis
31 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources